IDT Australia jumps most in 8 months on manufacturing COVID-19 vaccine candidate

IDT Australia

30/11/2021 02:45

** Shares of pharmaceutical co IDT Australia  IDT.AX  climb
as much as 55.2% to A$0.675, set to notch its best session since
March 22 
    ** Co says it has successfully manufactured the mRNA drug
used for COVID-19 vaccine under its agreement with Monash
Insitute of Pharmaceutical Sciences  urn:newsml:reuters.com:*:nASX9dcjN
    ** Says drug will now be supplied to the Institute for use
in their upcoming clinical trial
    ** Adds that this is Australia's first mRNA vaccine
candidate 
    ** Stock hits highest since Oct 15 
    ** About 5.5 mln shares change hands, compared with the
30-day average volume of ~489k
    ** As of last close, stock has more than doubled in value
this year

 (Reporting by Navya Mittal)
 ((Navya.Mittal@thomsonreuters.com;))